For the first time, researchers show that deep learning algorithms perform similar to human experts when classifying blood samples from patients suffering from acute myeloid leukemia (AML). Their proof of concept study paves the way for an automated, standardized and on-hand sample analysis in the near future.
Click here for original story, leukemia diagnostics: AI-driven single blood cell classification
Source: ScienceDaily